The CN subjects were significantly less impaired (global CDR and MMSE), had significantly fewer APOE4 carriers, and had a significantly lower [18F]-florbetapir SUVR compared to all cognitively impaired AD groups (p < 0.001, all). The gene discussed is APOE; the disease is Alzheimer disease.